title: Presynaptic G-protein-coupled receptors dynamically modify vesicle fusion, synaptic cleft glutamate concentrations, and motor behavior.
abstract: Understanding how neuromodulators regulate behavior requires investigating their effects on functional neural systems, but also their underlying cellular mechanisms. Utilizing extensively characterized lamprey motor circuits, and the unique access to reticulospinal presynaptic terminals in the intact spinal cord that initiate these behaviors, we investigated effects of presynaptic G-protein-coupled receptors on locomotion from the systems level, to the molecular control of vesicle fusion. 5-HT inhibits neurotransmitter release via a Gbetagamma interaction with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex that promotes kiss-and-run vesicle fusion. In the lamprey spinal cord, we demonstrate that, although presynaptic 5-HT receptors inhibit evoked neurotransmitter release from reticulospinal command neurons, their activation does not abolish locomotion but rather modulates locomotor rhythms. Liberation of presynaptic Gbetagamma causes substantial inhibition of AMPA receptor-mediated synaptic responses but leaves NMDA receptor-mediated components of neurotransmission mostly intact. Because Gbetagamma binding to the SNARE complex is displaced by Ca(2+)-synaptotagmin binding, 5-HT-mediated inhibition displays Ca(2+) sensitivity. We show that, as Ca(2+) accumulates presynaptically during physiological bouts of activity, 5-HT/Gbetagamma-mediated presynaptic inhibition is relieved, leading to a frequency-dependent increase in synaptic concentrations of glutamate. This frequency-dependent phenomenon mirrors a shift in the vesicle fusion mode and a recovery of AMPA receptor-mediated EPSCs from inhibition without a modification of NMDA receptor EPSCs. We conclude that activation of presynaptic 5-HT G-protein-coupled receptors state-dependently alters vesicle fusion properties to shift the weight of NMDA versus AMPA receptor-mediated responses at excitatory synapses. We have therefore identified a novel mechanism in which modification of vesicle fusion modes may profoundly alter locomotor behavior.
authors.affiliation: Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
authors.forename: Tatyana
authors.initials: T
authors.lastname: Gerachshenko
authors.forename: Eric
authors.initials: E
authors.lastname: Schwartz
authors.forename: Adam
authors.initials: A
authors.lastname: Bleckert
authors.forename: Huzefa
authors.initials: H
authors.lastname: Photowala
authors.forename: Andrew
authors.initials: A
authors.lastname: Seymour
authors.forename: Simon
authors.initials: S
authors.lastname: Alford
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D018698:Glutamic Acid / Q000378:metabolism*; D007798:Lampreys; D008561:Membrane Fusion / Q000187:drug effects / Q000502:physiology*; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology*; D012701:Serotonin / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects / Q000502:physiology; D055366:Synaptic Potentials / Q000187:drug effects / Q000502:physiology; D013572:Synaptic Vesicles / Q000187:drug effects / Q000502:physiology*
chemical_list: D012701:Serotonin; D018698:Glutamic Acid
references.citation: J Comput Neurosci. 2001 Sep-Oct;11(2):183-200
references.pmid: 11717534
references.citation: Brain Res. 1990 Jan 8;506(2):297-302
references.pmid: 1967966
references.citation: Science. 1992 Nov 27;258(5087):1498-501
references.pmid: 1359647
references.citation: J Comp Neurol. 1985 Apr 22;234(4):501-22
references.pmid: 2859306
references.citation: J Neurophysiol. 2005 Aug;94(2):1392-404
references.pmid: 15872068
references.citation: J Neurosci. 1991 Jun;11(6):1496-507
references.pmid: 1675264
references.citation: Science. 1987 Apr 17;236(4799):312-4
references.pmid: 3563512
references.citation: Brain Res. 1985 Jan 28;325(1-2):302-6
references.pmid: 2858251
references.citation: J Neurophysiol. 2005 Feb;93(2):980-8
references.pmid: 15456802
references.citation: Acta Physiol Scand. 1973 Mar;87(3):320-33
references.pmid: 4348892
references.citation: Nat Neurosci. 2005 May;8(5):597-605
references.pmid: 15834421
references.citation: J Physiol. 1989 Jul;414:265-82
references.pmid: 2607432
references.citation: Nat Neurosci. 2008 Dec;11(12):1419-29
references.pmid: 18997790
references.citation: Brain Res Rev. 2008 Jan;57(1):183-91
references.pmid: 17928060
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17843-8
references.pmid: 17968015
references.citation: Brain Res. 1985 Jun 17;336(2):390-5
references.pmid: 2988706
references.citation: J Neurophysiol. 1993 Aug;70(2):695-709
references.pmid: 8105036
references.citation: Neurosci Lett. 1991 Jan 14;122(1):71-44
references.pmid: 1676146
references.citation: Science. 1992 Oct 23;258(5082):662-5
references.pmid: 1411575
references.citation: Prog Brain Res. 1989;80:321-7; discussion 315-9
references.pmid: 2699371
references.citation: J Neurophysiol. 2003 Sep;90(3):1714-27
references.pmid: 12736238
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4281-6
references.pmid: 16537522
references.citation: J Neurosci. 2006 Mar 15;26(11):3030-6
references.pmid: 16540581
references.citation: J Neurophysiol. 1999 Apr;81(4):1513-30
references.pmid: 10200188
references.citation: Nature. 2007 Mar 29;446(7135):567-71
references.pmid: 17392788
references.citation: J Neurophysiol. 2006 Aug;96(2):931-5
references.pmid: 16707720
references.citation: Nat Neurosci. 2005 Apr;8(4):421-5
references.pmid: 15778713
references.citation: Neuron. 2006 Jan 19;49(2):243-56
references.pmid: 16423698
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20576-81
references.pmid: 18077369
references.citation: Mol Pharmacol. 2007 Nov;72(5):1210-9
references.pmid: 17715396
references.citation: Brain Res. 1987 Apr 7;408(1-2):321-5
references.pmid: 2885068
references.citation: J Neurophysiol. 2006 Mar;95(3):1545-55
references.pmid: 16338993
references.citation: J Physiol. 2001 Apr 15;532(Pt 2):323-36
references.pmid: 11306653
references.citation: J Neurosci. 2007 May 30;27(22):5857-68
references.pmid: 17537956
references.citation: Brain Res Rev. 2008 Jan;57(1):172-82
references.pmid: 17916380
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):695-705
references.pmid: 12740115
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1997 Sep;356(3):328-34
references.pmid: 9303569
references.citation: J Neurosci. 1999 Mar 1;19(5):1647-56
references.pmid: 10024351
references.citation: Science. 2001 Apr 13;292(5515):293-7
references.pmid: 11303105
references.citation: Neurosci Lett. 1989 May 22;100(1-3):188-92
references.pmid: 2668801
references.citation: Brain Res. 1989 Apr 10;484(1-2):203-16
references.pmid: 2713681
references.citation: J Physiol. 1984 Feb;347:225-39
references.pmid: 6142945
references.citation: Nature. 1995 Mar 16;374(6519):266-8
references.pmid: 7885446
references.citation: Brain Res. 1986 Aug 20;380(2):244-52
references.pmid: 2428424
references.citation: Eur J Neurosci. 2007 Sep;26(5):1205-12
references.pmid: 17767499
references.citation: Nature. 2006 Nov 2;444(7115):102-5
references.pmid: 17065984
references.citation: Neuron. 1999 Dec;24(4):809-17
references.pmid: 10624945
references.citation: Pharmacol Rev. 2006 Dec;58(4):837-62
references.pmid: 17132857
references.citation: Electroencephalogr Clin Neurophysiol. 1969 May;26(5):549
references.pmid: 4181500
references.citation: J Neurosci. 2005 Aug 31;25(35):7993-9
references.pmid: 16135756
references.citation: Science. 2009 Mar 13;323(5920):1448-53
references.pmid: 19213879
references.citation: J Neurosci. 2001 Oct 1;21(19):7793-803
references.pmid: 11567070
references.citation: Eur J Neurosci. 2000 Nov;12(11):4081-92
references.pmid: 11069605
references.citation: J Exp Biol. 1985 May;116:27-46
references.pmid: 4056654